CPRX Q2 2020 Earnings — Catalyst Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

CPRXCatalyst Pharmaceuticals, Inc.

$3B

Q2 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$30M+2.7% YoY

Gross Profit

$25M86.0% margin

Operating Income

$10M34.7% margin

Net Income

$10M33.0% margin

EPS (Diluted)

$0.09

QoQ Revenue Growth

+1.6%

Cash Flow

Operating Cash Flow

$13M

Free Cash Flow

$13M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$131M

Total Liabilities

$20M

Stockholders' Equity

$111M

Cash & Equivalents

$115M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$30M	$29M	+2.7%
Gross Profit	$25M	$25M	+3.6%
Operating Income	$10M	$11M	-6.2%
Net Income	$10M	$11M	-10.8%